Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Perrigo Co's share price for the quarter that ended in Mar. 2024 was R$153.3. Perrigo Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 136 Mil. Therefore, Perrigo Co's market cap for the quarter that ended in Mar. 2024 was R$20,895 Mil.
Perrigo Co's quarterly market cap
declined
from Sep. 2023 (R$22,734 Mil) to Dec. 2023 (R$20,276 Mil) but then
increased
from Dec. 2023 (R$20,276 Mil) to Mar. 2024 (R$20,895 Mil).
Perrigo Co's annual market cap
increased
from Dec. 2021 (R$27,121 Mil) to Dec. 2022 (R$27,525 Mil) but then
declined
from Dec. 2022 (R$27,525 Mil) to Dec. 2023 (R$20,276 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Perrigo Co's Enterprise Value for Today is R$38,409 Mil.
Perrigo Co Market Cap Historical Data
The historical data trend for Perrigo Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Market Cap falls into.
Perrigo Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Perrigo Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (BSP:P1RG34) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Perrigo Co Market Cap Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:P1RG34 has been successfully added to your 